Show simple item record

dc.contributor.authorDe Boer, R.
dc.contributor.authorKotasek, D.
dc.contributor.authorWhite, S.
dc.contributor.authorKoczwara, B.
dc.contributor.authorMainwaring, P.
dc.contributor.authorChan, Arlene
dc.contributor.authorMelara, R.
dc.contributor.authorYe, Y.
dc.contributor.authorAdewoye, A.
dc.contributor.authorSikorski, R.
dc.contributor.authorKaufman, P.
dc.date.accessioned2017-01-30T12:08:21Z
dc.date.available2017-01-30T12:08:21Z
dc.date.created2014-11-19T01:13:18Z
dc.date.issued2012
dc.identifier.citationDe Boer, R. and Kotasek, D. and White, S. and Koczwara, B. and Mainwaring, P. and Chan, A. and Melara, R. et al. 2012. Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 135 (1): pp. 241-252.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/18532
dc.publisherSpringer New York LLC
dc.titlePhase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
dc.typeJournal Article
dcterms.source.volume135
dcterms.source.number1
dcterms.source.startPage241
dcterms.source.endPage252
dcterms.source.issn01676806
dcterms.source.titleBreast Cancer Research and Treatment
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record